HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 1/2

NCT04180215

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

This is a First in Human (FIH) Phase I/II, multinational, multicenter, open-label study of HB-201 single vector therapy and HB-201 \& HB-202 two-vector therapy…

United States198 participantsStarted 2019-12-11

Treatment: HB-201 intravenous administration., HB-202 intravenous administration alternating with HB-201 intravenous administration.

TerminatedEarly Phase 1

NCT04630353

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

This Window of Opportunity clinical trial will examine the immunologic effects of the study agent HB-201 in the head and neck or cervical cancer, when administe…

United States10 participantsStarted 2021-07-28

Treatment: HB-201 IV, HB-201 IV